UroGen Pharma
URGN
#6839
Rank
โ‚ฌ0.40 B
Marketcap
8,79ย โ‚ฌ
Share price
-3.51%
Change (1 day)
-27.95%
Change (1 year)

Revenue for UroGen Pharma (URGN)

Revenue in 2024 (TTM): โ‚ฌ83.94 Million

According to UroGen Pharma's latest financial reports the company's current revenue (TTM ) is โ‚ฌ82.66 Million. an increase over the revenue in the year 2023 that were of โ‚ฌ74.82 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for UroGen Pharma from 2017 to 2024

Annual revenue

Year Revenue Change
2024 โ‚ฌ86.86 M16.1%
2023 โ‚ฌ74.82 M24.71%
2022 โ‚ฌ59.99 M41.43%
2021 โ‚ฌ42.42 M342.22%
2020 โ‚ฌ9.59 M59600.56%
2019 โ‚ฌ0.01 M-98.37%
2018 โ‚ฌ0.98 M-85.5%
2017 โ‚ฌ6.79 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA